story of the week
Belzutifan for von Hippel–Lindau Disease–Associated Pancreatic Lesions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study
Clin. Cancer Res 2024 Feb 23;[EPub Ahead of Print], T Else, E Jonasch, O Lliopoulos, KE Beckermann, V Narayan, BL Maughan, S Oudard, JK Maranchie, AB Iversen, CM Goldberg, W Fu, RF Perini, Y Liu, WM Linehan, R SrinivasanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.